Dr. Peter Gardiner

Peter Gardiner

Title: Chief Medical Officer
Company: Blue Earth Diagnostics
Location: Groton, Massachusetts, United States

Dr. Peter Gardiner, chief medical officer at Blue Earth Diagnostics, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in pharmaceuticals.

An enthusiastic and adaptable student, Dr. Gardiner was drawn to the medical field from an early age. First earning his Bachelor of Medicine, Bachelor of Surgery from the School of Medicine at the University of Leeds in 1975, he went on to complete a medicine and surgery internship and a training rotation in internal medicine and cardiology at the Bradford Teaching Hospitals between 1975 and 1980. After spending three years at the Cardiothoracic Centre of the Freeman Hospital, he left England to begin postgraduate coursework at the University of Wales, graduating with a diploma in pharmaceutical medicine, while employed at G.D. Searle, LLC. In 1986, he accepted a position with G.D. Searle in Skokie, Illinois, during which time he concluded his formal studies with advanced training in biomedical research management at the Harvard T.H. Chan School of Public Health.

Dr. Gardiner went on to hold leadership positions with Gensia Pharmaceuticals, where he was presented with a Distinguished Achievement Award; DuPont Pharmaceuticals Co.; Bristol-Myers Squibb Medical Imaging; and BG Medicine. In 2008, he established Gardiner Consulting, LLC, where he is the senior pharmaceutical physician and president. Dr. Gardiner has been affiliated with Blue Earth Diagnostics as a senior pharmaceutical physician since 2016 and as chief medical officer since 2017, roles in which he is responsible for all the medical oversight for the company. He considers the highlight of his career to be his involvement in the development, approval and launch of several new drugs, one of which has aided roughly 150,000 men with prostate cancer in the United States. Dr. Gardiner is also proud of his work leading a group of 110 people involved in clinical research and medical and regulatory affairs across the United States, Europe, and Canada.

Contact Dr. Gardiner:

Leave a Reply